Global and United States Recombinant Therapeutic Protein Market Insights, Forecast to 2026

Global and United States Recombinant Therapeutic Protein Market Insights, Forecast to 2026

Table of Contents
1 Study Coverage
1.1 Recombinant Therapeutic Protein Product Introduction
1.2 Market Segments
1.3 Key Recombinant Therapeutic Protein Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Recombinant Therapeutic Protein Market Size Growth Rate by Type
1.4.2 Recombinant Human Collage
1.4.3 Recombinant Human Serum Albumin
1.5 Market by Application
1.5.1 Global Recombinant Therapeutic Protein Market Size Growth Rate by Application
1.5.2 Medicine
1.5.3 Scientific Research
1.5.4 Others
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Recombinant Therapeutic Protein Market Size, Estimates and Forecasts
2.1.1 Global Recombinant Therapeutic Protein Revenue 2015-2026
2.1.2 Global Recombinant Therapeutic Protein Sales 2015-2026
2.2 Global Recombinant Therapeutic Protein, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.3 Recombinant Therapeutic Protein Historical Market Size by Region (2015-2020)
2.3.1 Global Recombinant Therapeutic Protein Retrospective Market Scenario in Sales by Region: 2015-2020
2.3.2 Global Recombinant Therapeutic Protein Retrospective Market Scenario in Revenue by Region: 2015-2020
2.4 Recombinant Therapeutic Protein Market Estimates and Projections by Region (2021-2026)
2.4.1 Global Recombinant Therapeutic Protein Sales Forecast by Region (2021-2026)
2.4.2 Global Recombinant Therapeutic Protein Revenue Forecast by Region (2021-2026)
3 Global Recombinant Therapeutic Protein Competitor Landscape by Players
3.1 Global Top Recombinant Therapeutic Protein Sales by Manufacturers
3.1.1 Global Recombinant Therapeutic Protein Sales by Manufacturers (2015-2020)
3.1.2 Global Recombinant Therapeutic Protein Sales Market Share by Manufacturers (2015-2020)
3.2 Global Recombinant Therapeutic Protein Manufacturers by Revenue
3.2.1 Global Recombinant Therapeutic Protein Revenue by Manufacturers (2015-2020)
3.2.2 Global Recombinant Therapeutic Protein Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Recombinant Therapeutic Protein Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Recombinant Therapeutic Protein Revenue in 2019
3.2.5 Global Recombinant Therapeutic Protein Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Global Recombinant Therapeutic Protein Price by Manufacturers
3.4 Global Recombinant Therapeutic Protein Manufacturing Base Distribution, Product Types
3.4.1 Recombinant Therapeutic Protein Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Recombinant Therapeutic Protein Product Type
3.4.3 Date of International Manufacturers Enter into Recombinant Therapeutic Protein Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Recombinant Therapeutic Protein Market Size by Type (2015-2020)
4.1.1 Global Recombinant Therapeutic Protein Sales by Type (2015-2020)
4.1.2 Global Recombinant Therapeutic Protein Revenue by Type (2015-2020)
4.1.3 Recombinant Therapeutic Protein Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Recombinant Therapeutic Protein Market Size Forecast by Type (2021-2026)
4.2.1 Global Recombinant Therapeutic Protein Sales Forecast by Type (2021-2026)
4.2.2 Global Recombinant Therapeutic Protein Revenue Forecast by Type (2021-2026)
4.2.3 Recombinant Therapeutic Protein Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Recombinant Therapeutic Protein Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Recombinant Therapeutic Protein Market Size by Application (2015-2020)
5.1.1 Global Recombinant Therapeutic Protein Sales by Application (2015-2020)
5.1.2 Global Recombinant Therapeutic Protein Revenue by Application (2015-2020)
5.1.3 Recombinant Therapeutic Protein Price by Application (2015-2020)
5.2 Recombinant Therapeutic Protein Market Size Forecast by Application (2021-2026)
5.2.1 Global Recombinant Therapeutic Protein Sales Forecast by Application (2021-2026)
5.2.2 Global Recombinant Therapeutic Protein Revenue Forecast by Application (2021-2026)
5.2.3 Global Recombinant Therapeutic Protein Price Forecast by Application (2021-2026)
6 United States by Players, Type and Application
6.1 United States Recombinant Therapeutic Protein Market Size YoY Growth 2015-2026
6.1.1 United States Recombinant Therapeutic Protein Sales YoY Growth 2015-2026
6.1.2 United States Recombinant Therapeutic Protein Revenue YoY Growth 2015-2026
6.1.3 United States Recombinant Therapeutic Protein Market Share in Global Market 2015-2026
6.2 United States Recombinant Therapeutic Protein Market Size by Players (International and Local Players)
6.2.1 United States Top Recombinant Therapeutic Protein Players by Sales (2015-2020)
6.2.2 United States Top Recombinant Therapeutic Protein Players by Revenue (2015-2020)
6.3 United States Recombinant Therapeutic Protein Historic Market Review by Type (2015-2020)
6.3.1 United States Recombinant Therapeutic Protein Sales Market Share by Type (2015-2020)
6.3.2 United States Recombinant Therapeutic Protein Revenue Market Share by Type (2015-2020)
6.3.3 United States Recombinant Therapeutic Protein Price by Type (2015-2020)
6.4 United States Recombinant Therapeutic Protein Market Estimates and Forecasts by Type (2021-2026)
6.4.1 United States Recombinant Therapeutic Protein Sales Forecast by Type (2021-2026)
6.4.2 United States Recombinant Therapeutic Protein Revenue Forecast by Type (2021-2026)
6.4.3 United States Recombinant Therapeutic Protein Price Forecast by Type (2021-2026)
6.5 United States Recombinant Therapeutic Protein Historic Market Review by Application (2015-2020)
6.5.1 United States Recombinant Therapeutic Protein Sales Market Share by Application (2015-2020)
6.5.2 United States Recombinant Therapeutic Protein Revenue Market Share by Application (2015-2020)
6.5.3 United States Recombinant Therapeutic Protein Price by Application (2015-2020)
6.6 United States Recombinant Therapeutic Protein Market Estimates and Forecasts by Application (2021-2026)
6.6.1 United States Recombinant Therapeutic Protein Sales Forecast by Application (2021-2026)
6.6.2 United States Recombinant Therapeutic Protein Revenue Forecast by Application (2021-2026)
6.6.3 United States Recombinant Therapeutic Protein Price Forecast by Application (2021-2026)
7 North America
7.1 North America Recombinant Therapeutic Protein Market Size YoY Growth 2015-2026
7.2 North America Recombinant Therapeutic Protein Market Facts & Figures by Country
7.2.1 North America Recombinant Therapeutic Protein Sales by Country (2015-2020)
7.2.2 North America Recombinant Therapeutic Protein Revenue by Country (2015-2020)
7.2.3 U.S.
7.2.4 Canada
8 Europe
8.1 Europe Recombinant Therapeutic Protein Market Size YoY Growth 2015-2026
8.2 Europe Recombinant Therapeutic Protein Market Facts & Figures by Country
8.2.1 Europe Recombinant Therapeutic Protein Sales by Country
8.2.2 Europe Recombinant Therapeutic Protein Revenue by Country
8.2.3 Germany
8.2.4 France
8.2.5 U.K.
8.2.6 Italy
8.2.7 Russia
9 Asia Pacific
9.1 Asia Pacific Recombinant Therapeutic Protein Market Size YoY Growth 2015-2026
9.2 Asia Pacific Recombinant Therapeutic Protein Market Facts & Figures by Country
9.2.1 Asia Pacific Recombinant Therapeutic Protein Sales by Region (2015-2020)
9.2.2 Asia Pacific Recombinant Therapeutic Protein Revenue by Region
9.2.3 China
9.2.4 Japan
9.2.5 South Korea
9.2.6 India
9.2.7 Australia
9.2.8 Taiwan
9.2.9 Indonesia
9.2.10 Thailand
9.2.11 Malaysia
9.2.12 Philippines
9.2.13 Vietnam
10 Latin America
10.1 Latin America Recombinant Therapeutic Protein Market Size YoY Growth 2015-2026
10.2 Latin America Recombinant Therapeutic Protein Market Facts & Figures by Country
10.2.1 Latin America Recombinant Therapeutic Protein Sales by Country
10.2.2 Latin America Recombinant Therapeutic Protein Revenue by Country
10.2.3 Mexico
10.2.4 Brazil
10.2.5 Argentina
11 Middle East and Africa
11.1 Middle East and Africa Recombinant Therapeutic Protein Market Size YoY Growth 2015-2026
11.2 Middle East and Africa Recombinant Therapeutic Protein Market Facts & Figures by Country
11.2.1 Middle East and Africa Recombinant Therapeutic Protein Sales by Country
11.2.2 Middle East and Africa Recombinant Therapeutic Protein Revenue by Country
11.2.3 Turkey
11.2.4 Saudi Arabia
11.2.5 U.A.E
12 Company Profiles
12.1 Boehringer Ingelheim
12.1.1 Boehringer Ingelheim Corporation Information
12.1.2 Boehringer Ingelheim Description and Business Overview
12.1.3 Boehringer Ingelheim Sales, Revenue and Gross Margin (2015-2020)
12.1.4 Boehringer Ingelheim Recombinant Therapeutic Protein Products Offered
12.1.5 Boehringer Ingelheim Recent Development
12.2 Bristol-Myers Squibb
12.2.1 Bristol-Myers Squibb Corporation Information
12.2.2 Bristol-Myers Squibb Description and Business Overview
12.2.3 Bristol-Myers Squibb Sales, Revenue and Gross Margin (2015-2020)
12.2.4 Bristol-Myers Squibb Recombinant Therapeutic Protein Products Offered
12.2.5 Bristol-Myers Squibb Recent Development
12.3 Celldex Therapeutics
12.3.1 Celldex Therapeutics Corporation Information
12.3.2 Celldex Therapeutics Description and Business Overview
12.3.3 Celldex Therapeutics Sales, Revenue and Gross Margin (2015-2020)
12.3.4 Celldex Therapeutics Recombinant Therapeutic Protein Products Offered
12.3.5 Celldex Therapeutics Recent Development
12.4 Eli Liily
12.4.1 Eli Liily Corporation Information
12.4.2 Eli Liily Description and Business Overview
12.4.3 Eli Liily Sales, Revenue and Gross Margin (2015-2020)
12.4.4 Eli Liily Recombinant Therapeutic Protein Products Offered
12.4.5 Eli Liily Recent Development
12.5 GlaxoSmithKline
12.5.1 GlaxoSmithKline Corporation Information
12.5.2 GlaxoSmithKline Description and Business Overview
12.5.3 GlaxoSmithKline Sales, Revenue and Gross Margin (2015-2020)
12.5.4 GlaxoSmithKline Recombinant Therapeutic Protein Products Offered
12.5.5 GlaxoSmithKline Recent Development
12.6 Merck
12.6.1 Merck Corporation Information
12.6.2 Merck Description and Business Overview
12.6.3 Merck Sales, Revenue and Gross Margin (2015-2020)
12.6.4 Merck Recombinant Therapeutic Protein Products Offered
12.6.5 Merck Recent Development
12.7 Novartis
12.7.1 Novartis Corporation Information
12.7.2 Novartis Description and Business Overview
12.7.3 Novartis Sales, Revenue and Gross Margin (2015-2020)
12.7.4 Novartis Recombinant Therapeutic Protein Products Offered
12.7.5 Novartis Recent Development
12.8 Regeneron Pharmaceuticals
12.8.1 Regeneron Pharmaceuticals Corporation Information
12.8.2 Regeneron Pharmaceuticals Description and Business Overview
12.8.3 Regeneron Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
12.8.4 Regeneron Pharmaceuticals Recombinant Therapeutic Protein Products Offered
12.8.5 Regeneron Pharmaceuticals Recent Development
12.9 Roche
12.9.1 Roche Corporation Information
12.9.2 Roche Description and Business Overview
12.9.3 Roche Sales, Revenue and Gross Margin (2015-2020)
12.9.4 Roche Recombinant Therapeutic Protein Products Offered
12.9.5 Roche Recent Development
12.10 Takeda
12.10.1 Takeda Corporation Information
12.10.2 Takeda Description and Business Overview
12.10.3 Takeda Sales, Revenue and Gross Margin (2015-2020)
12.10.4 Takeda Recombinant Therapeutic Protein Products Offered
12.10.5 Takeda Recent Development
12.11 Boehringer Ingelheim
12.11.1 Boehringer Ingelheim Corporation Information
12.11.2 Boehringer Ingelheim Description and Business Overview
12.11.3 Boehringer Ingelheim Sales, Revenue and Gross Margin (2015-2020)
12.11.4 Boehringer Ingelheim Recombinant Therapeutic Protein Products Offered
12.11.5 Boehringer Ingelheim Recent Development
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter's Five Forces Analysis
13.5 Primary Interviews with Key Recombinant Therapeutic Protein Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Recombinant Therapeutic Protein Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
List of Tables
Table 1. Recombinant Therapeutic Protein Market Segments
Table 2. Ranking of Global Top Recombinant Therapeutic Protein Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Recombinant Therapeutic Protein Market Size Growth Rate by Type 2020-2026 (K MT) & (US$ Million)
Table 4. Major Manufacturers of Recombinant Human Collage
Table 5. Major Manufacturers of Recombinant Human Serum Albumin
Table 6. Global Recombinant Therapeutic Protein Market Size Growth Rate by Application 2020-2026 (K MT)
Table 7. Global Recombinant Therapeutic Protein Market Size by Region (K MT) & (US$ Million): 2020 VS 2026
Table 8. Global Recombinant Therapeutic Protein Sales by Regions 2015-2020 (K MT)
Table 9. Global Recombinant Therapeutic Protein Sales Market Share by Regions (2015-2020)
Table 10. Global Recombinant Therapeutic Protein Revenue by Regions 2015-2020 (US$ Million)
Table 11. Global Recombinant Therapeutic Protein Sales Forecast by Region (2021-2026) (K MT)
Table 12. Global Recombinant Therapeutic Protein Sales by Manufacturers (2015-2020) (K MT)
Table 13. Global Recombinant Therapeutic Protein Sales Share by Manufacturers (2015-2020)
Table 14. Global Recombinant Therapeutic Protein Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 15. Global Recombinant Therapeutic Protein by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Recombinant Therapeutic Protein as of 2019)
Table 16. Recombinant Therapeutic Protein Revenue by Manufacturers (2015-2020) (US$ Million)
Table 17. Recombinant Therapeutic Protein Revenue Share by Manufacturers (2015-2020)
Table 18. Key Manufacturers Recombinant Therapeutic Protein Price (2015-2020) (USD/MT)
Table 19. Recombinant Therapeutic Protein Manufacturers Manufacturing Base Distribution and Headquarters
Table 20. Manufacturers Recombinant Therapeutic Protein Product Type
Table 21. Date of International Manufacturers Enter into Recombinant Therapeutic Protein Market
Table 22. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 23. Global Recombinant Therapeutic Protein Sales by Type (2015-2020) (K MT)
Table 24. Global Recombinant Therapeutic Protein Sales Share by Type (2015-2020)
Table 25. Global Recombinant Therapeutic Protein Revenue by Type (2015-2020) (US$ Million)
Table 26. Global Recombinant Therapeutic Protein Revenue Share by Type (2015-2020)
Table 27. Recombinant Therapeutic Protein Average Selling Price (ASP) by Type 2015-2020 (USD/MT)
Table 28. Global Recombinant Therapeutic Protein Sales Share by Type (2021-2026)
Table 29. Global Recombinant Therapeutic Protein Sales by Application (2015-2020) (K MT)
Table 30. Global Recombinant Therapeutic Protein Sales Share by Application (2015-2020)
Table 31. Global Recombinant Therapeutic Protein Sales Share by Application (2021-2026)
Table 32. Global Recombinant Therapeutic Protein Sales Market Share Forecast by Application (2021-2026)
Table 33. Global Recombinant Therapeutic Protein Revenue by Application (2015-2020) (US$ Million)
Table 34. Global Recombinant Therapeutic Protein Revenue Market Share Forecast by Application (2021-2026)
Table 35. United States Recombinant Therapeutic Protein Sales (K MT) of Key Companies (2015-2020)
Table 36. United States Recombinant Therapeutic Protein Sales Share by Company (2015-2020)
Table 37. United States Recombinant Therapeutic Protein Revenue (US$ Million) by Company (2015-2020)
Table 38. United States Recombinant Therapeutic Protein Sales (K MT) by Type (2015-2020)
Table 39. United States Recombinant Therapeutic Protein Sales Share by Type (2015-2020)
Table 40. United States Recombinant Therapeutic Protein Revenue (US$ Million) Market Share by Type (2015-2020)
Table 41. United States Recombinant Therapeutic Protein Price (K MT) by Type (2015-2020)
Table 42. United States Recombinant Therapeutic Protein Sales (K MT) by Type (2021-2026)
Table 43. United States Recombinant Therapeutic Protein Sales Share by Type (2021-2026)
Table 44. United States Recombinant Therapeutic Protein Revenue (US$ Million) Market Share by Type (2021-2026)
Table 45. United States Recombinant Therapeutic Protein Revenue Share by Type (2021-2026)
Table 46. United States Recombinant Therapeutic Protein Price (K MT) by Type (2021-2026)
Table 47. United States Recombinant Therapeutic Protein Sales (K MT) by Application (2015-2020)
Table 48. United States Recombinant Therapeutic Protein Sales Share by Application (2015-2020)
Table 49. United States Recombinant Therapeutic Protein Revenue (US$ Million) Market Share by Application (2015-2020)
Table 50. United States Recombinant Therapeutic Protein Sales (K MT) by Application (2021-2026)
Table 51. United States Recombinant Therapeutic Protein Sales Share by Application (2021-2026)
Table 52. United States Recombinant Therapeutic Protein Revenue (US$ Million) Market Share by Application (2021-2026)
Table 53. United States Recombinant Therapeutic Protein Revenue Share by Application (2021-2026)
Table 54. North America Recombinant Therapeutic Protein Sales by Country (2015-2020) (K MT)
Table 55. North America Recombinant Therapeutic Protein Sales Market Share by Country (2015-2020)
Table 56. North America Recombinant Therapeutic Protein Revenue by Country (2015-2020) (US$ Million)
Table 57. North America Recombinant Therapeutic Protein Revenue Market Share by Country (2015-2020)
Table 58. Europe Recombinant Therapeutic Protein Sales by Country (2015-2020) (K MT)
Table 59. Europe Recombinant Therapeutic Protein Sales Market Share by Country (2015-2020)
Table 60. Europe Recombinant Therapeutic Protein Revenue by Country (2015-2020) (US$ Million)
Table 61. Europe Recombinant Therapeutic Protein Revenue Market Share by Country (2015-2020)
Table 62. Asia Pacific Recombinant Therapeutic Protein Sales by Region (2015-2020) (K MT)
Table 63. Asia Pacific Recombinant Therapeutic Protein Sales Market Share by Region (2015-2020)
Table 64. Asia Pacific Recombinant Therapeutic Protein Revenue by Region (2015-2020) (US$ Million)
Table 65. Asia Pacific Recombinant Therapeutic Protein Revenue Market Share by Region (2015-2020)
Table 66. Latin America Recombinant Therapeutic Protein Sales by Country (2015-2020) (K MT)
Table 67. Latin America Recombinant Therapeutic Protein Sales Market Share by Country (2015-2020)
Table 68. Latin Americaa Recombinant Therapeutic Protein Revenue by Country (2015-2020) (US$ Million)
Table 69. Latin America Recombinant Therapeutic Protein Revenue Market Share by Country (2015-2020)
Table 70. Middle East and Africa Recombinant Therapeutic Protein Sales by Country (2015-2020) (K MT)
Table 71. Middle East and Africa Recombinant Therapeutic Protein Sales Market Share by Country (2015-2020)
Table 72. Middle East and Africa Recombinant Therapeutic Protein Revenue by Country (2015-2020) (US$ Million)
Table 73. Middle East and Africa Recombinant Therapeutic Protein Revenue Market Share by Country (2015-2020)
Table 74. Boehringer Ingelheim Corporation Information
Table 75. Boehringer Ingelheim Description and Business Overview
Table 76. Boehringer Ingelheim Recombinant Therapeutic Protein Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 77. Boehringer Ingelheim Recombinant Therapeutic Protein Product
Table 78. Boehringer Ingelheim Recent Development
Table 79. Bristol-Myers Squibb Corporation Information
Table 80. Bristol-Myers Squibb Description and Business Overview
Table 81. Bristol-Myers Squibb Recombinant Therapeutic Protein Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 82. Bristol-Myers Squibb Product
Table 83. Bristol-Myers Squibb Recent Development
Table 84. Celldex Therapeutics Corporation Information
Table 85. Celldex Therapeutics Description and Business Overview
Table 86. Celldex Therapeutics Recombinant Therapeutic Protein Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 87. Celldex Therapeutics Product
Table 88. Celldex Therapeutics Recent Development
Table 89. Eli Liily Corporation Information
Table 90. Eli Liily Description and Business Overview
Table 91. Eli Liily Recombinant Therapeutic Protein Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 92. Eli Liily Product
Table 93. Eli Liily Recent Development
Table 94. GlaxoSmithKline Corporation Information
Table 95. GlaxoSmithKline Description and Business Overview
Table 96. GlaxoSmithKline Recombinant Therapeutic Protein Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 97. GlaxoSmithKline Product
Table 98. GlaxoSmithKline Recent Development
Table 99. Merck Corporation Information
Table 100. Merck Description and Business Overview
Table 101. Merck Recombinant Therapeutic Protein Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 102. Merck Product
Table 103. Merck Recent Development
Table 104. Novartis Corporation Information
Table 105. Novartis Description and Business Overview
Table 106. Novartis Recombinant Therapeutic Protein Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 107. Novartis Product
Table 108. Novartis Recent Development
Table 109. Regeneron Pharmaceuticals Corporation Information
Table 110. Regeneron Pharmaceuticals Description and Business Overview
Table 111. Regeneron Pharmaceuticals Recombinant Therapeutic Protein Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 112. Regeneron Pharmaceuticals Product
Table 113. Regeneron Pharmaceuticals Recent Development
Table 114. Roche Corporation Information
Table 115. Roche Description and Business Overview
Table 116. Roche Recombinant Therapeutic Protein Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 117. Roche Product
Table 118. Roche Recent Development
Table 119. Takeda Corporation Information
Table 120. Takeda Description and Business Overview
Table 121. Takeda Recombinant Therapeutic Protein Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 122. Takeda Product
Table 123. Takeda Recent Development
Table 124. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 125. Key Challenges
Table 126. Market Risks
Table 127. Main Points Interviewed from Key Recombinant Therapeutic Protein Players
Table 128. Recombinant Therapeutic Protein Customers List
Table 129. Recombinant Therapeutic Protein Distributors List
Table 130. Research Programs/Design for This Report
Table 131. Key Data Information from Secondary Sources
Table 132. Key Data Information from Primary Sources
List of Figures
Figure 1. Recombinant Therapeutic Protein Product Picture
Figure 2. Global Recombinant Therapeutic Protein Sales Market Share by Type in 2020 & 2026
Figure 3. Recombinant Human Collage Product Picture
Figure 4. Recombinant Human Serum Albumin Product Picture
Figure 5. Global Recombinant Therapeutic Protein Sales Market Share by Application in 2020 & 2026
Figure 6. Medicine
Figure 7. Scientific Research
Figure 8. Others
Figure 9. Recombinant Therapeutic Protein Report Years Considered
Figure 10. Global Recombinant Therapeutic Protein Market Size 2015-2026 (US$ Million)
Figure 11. Global Recombinant Therapeutic Protein Sales 2015-2026 (K MT)
Figure 12. Global Recombinant Therapeutic Protein Market Size Market Share by Region: 2020 Versus 2026
Figure 13. Global Recombinant Therapeutic Protein Sales Market Share by Region (2015-2020)
Figure 14. Global Recombinant Therapeutic Protein Sales Market Share by Region in 2019
Figure 15. Global Recombinant Therapeutic Protein Revenue Market Share by Region (2015-2020)
Figure 16. Global Recombinant Therapeutic Protein Revenue Market Share by Region in 2019
Figure 17. Global Recombinant Therapeutic Protein Sales Share by Manufacturer in 2019
Figure 18. The Top 10 and 5 Players Market Share by Recombinant Therapeutic Protein Revenue in 2019
Figure 19. Recombinant Therapeutic Protein Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 20. Global Recombinant Therapeutic Protein Sales Market Share by Type (2015-2020)
Figure 21. Global Recombinant Therapeutic Protein Sales Market Share by Type in 2019
Figure 22. Global Recombinant Therapeutic Protein Revenue Market Share by Type (2015-2020)
Figure 23. Global Recombinant Therapeutic Protein Revenue Market Share by Type in 2019
Figure 24. Global Recombinant Therapeutic Protein Market Share by Price Range (2015-2020)
Figure 25. Global Recombinant Therapeutic Protein Sales Market Share by Application (2015-2020)
Figure 26. Global Recombinant Therapeutic Protein Sales Market Share by Application in 2019
Figure 27. Global Recombinant Therapeutic Protein Revenue Market Share by Application (2015-2020)
Figure 28. Global Recombinant Therapeutic Protein Revenue Market Share by Application in 2019
Figure 29. United States Recombinant Therapeutic Protein Sales Growth Rate 2015-2026 (K MT)
Figure 30. United States Recombinant Therapeutic Protein Revenue Growth Rate 2015-2026 (US$ Million)
Figure 31. United States Recombinant Therapeutic Protein Market Share in Global Market 2015-2026
Figure 32. United States 5 and 10 Largest Recombinant Therapeutic Protein Players Market Share by Revenue in Recombinant Therapeutic Protein in 2019
Figure 33. United States Recombinant Therapeutic Protein Revenue Share by Type (2015-2020)
Figure 34. United States Recombinant Therapeutic Protein Revenue Growth Rate by Type in 2015 & 2019
Figure 35. United States Recombinant Therapeutic Protein Revenue Share by Application (2015-2020)
Figure 36. United States Recombinant Therapeutic Protein Revenue Growth Rate by Application in 2015 & 2019
Figure 37. North America Recombinant Therapeutic Protein Sales Growth Rate 2015-2020 (K MT)
Figure 38. North America Recombinant Therapeutic Protein Revenue Growth Rate 2015-2020 (US$ Million)
Figure 39. North America Recombinant Therapeutic Protein Sales Market Share by Country in 2019
Figure 40. North America Recombinant Therapeutic Protein Revenue Market Share by Country in 2019
Figure 41. U.S. Recombinant Therapeutic Protein Sales Growth Rate (2015-2020) (K MT)
Figure 42. U.S. Recombinant Therapeutic Protein Revenue Growth Rate (2015-2020) (US$ Million)
Figure 43. Canada Recombinant Therapeutic Protein Sales Growth Rate (2015-2020) (K MT)
Figure 44. Canada Recombinant Therapeutic Protein Revenue Growth Rate (2015-2020) (US$ Million)
Figure 45. Europe Recombinant Therapeutic Protein Sales Growth Rate 2015-2020 (K MT)
Figure 46. Europe Recombinant Therapeutic Protein Revenue Growth Rate 2015-2020 (US$ Million)
Figure 47. Europe Recombinant Therapeutic Protein Sales Market Share by Country in 2019
Figure 48. Europe Recombinant Therapeutic Protein Revenue Market Share by Country in 2019
Figure 49. Germany Recombinant Therapeutic Protein Sales Growth Rate (2015-2020) (K MT)
Figure 50. Germany Recombinant Therapeutic Protein Revenue Growth Rate (2015-2020) (US$ Million)
Figure 51. France Recombinant Therapeutic Protein Sales Growth Rate (2015-2020) (K MT)
Figure 52. France Recombinant Therapeutic Protein Revenue Growth Rate (2015-2020) (US$ Million)
Figure 53. U.K. Recombinant Therapeutic Protein Sales Growth Rate (2015-2020) (K MT)
Figure 54. U.K. Recombinant Therapeutic Protein Revenue Growth Rate (2015-2020) (US$ Million)
Figure 55. Italy Recombinant Therapeutic Protein Sales Growth Rate (2015-2020) (K MT)
Figure 56. Italy Recombinant Therapeutic Protein Revenue Growth Rate (2015-2020) (US$ Million)
Figure 57. Russia Recombinant Therapeutic Protein Sales Growth Rate (2015-2020) (K MT)
Figure 58. Russia Recombinant Therapeutic Protein Revenue Growth Rate (2015-2020) (US$ Million)
Figure 59. Asia Pacific Recombinant Therapeutic Protein Sales Growth Rate 2015-2020 (K MT)
Figure 60. Asia Pacific Recombinant Therapeutic Protein Revenue Growth Rate 2015-2020 (US$ Million)
Figure 61. Asia Pacific Recombinant Therapeutic Protein Sales Market Share by Region in 2019
Figure 62. Asia Pacific Recombinant Therapeutic Protein Revenue Market Share by Region in 2019
Figure 63. China Recombinant Therapeutic Protein Sales Growth Rate (2015-2020) (K MT)
Figure 64. China Recombinant Therapeutic Protein Revenue Growth Rate (2015-2020) (US$ Million)
Figure 65. Japan Recombinant Therapeutic Protein Sales Growth Rate (2015-2020) (K MT)
Figure 66. Japan Recombinant Therapeutic Protein Revenue Growth Rate (2015-2020) (US$ Million)
Figure 67. South Korea Recombinant Therapeutic Protein Sales Growth Rate (2015-2020) (K MT)
Figure 68. South Korea Recombinant Therapeutic Protein Revenue Growth Rate (2015-2020) (US$ Million)
Figure 69. India Recombinant Therapeutic Protein Sales Growth Rate (2015-2020) (K MT)
Figure 70. India Recombinant Therapeutic Protein Revenue Growth Rate (2015-2020) (US$ Million)
Figure 71. Australia Recombinant Therapeutic Protein Sales Growth Rate (2015-2020) (K MT)
Figure 72. Australia Recombinant Therapeutic Protein Revenue Growth Rate (2015-2020) (US$ Million)
Figure 73. Taiwan Recombinant Therapeutic Protein Sales Growth Rate (2015-2020) (K MT)
Figure 74. Taiwan Recombinant Therapeutic Protein Revenue Growth Rate (2015-2020) (US$ Million)
Figure 75. Indonesia Recombinant Therapeutic Protein Sales Growth Rate (2015-2020) (K MT)
Figure 76. Indonesia Recombinant Therapeutic Protein Revenue Growth Rate (2015-2020) (US$ Million)
Figure 77. Thailand Recombinant Therapeutic Protein Sales Growth Rate (2015-2020) (K MT)
Figure 78. Thailand Recombinant Therapeutic Protein Revenue Growth Rate (2015-2020) (US$ Million)
Figure 79. Malaysia Recombinant Therapeutic Protein Sales Growth Rate (2015-2020) (K MT)
Figure 80. Malaysia Recombinant Therapeutic Protein Revenue Growth Rate (2015-2020) (US$ Million)
Figure 81. Philippines Recombinant Therapeutic Protein Sales Growth Rate (2015-2020) (K MT)
Figure 82. Philippines Recombinant Therapeutic Protein Revenue Growth Rate (2015-2020) (US$ Million)
Figure 83. Vietnam Recombinant Therapeutic Protein Sales Growth Rate (2015-2020) (K MT)
Figure 84. Vietnam Recombinant Therapeutic Protein Revenue Growth Rate (2015-2020) (US$ Million)
Figure 85. Latin America Recombinant Therapeutic Protein Sales Growth Rate 2015-2020 (K MT)
Figure 86. Latin America Recombinant Therapeutic Protein Revenue Growth Rate 2015-2020 (US$ Million)
Figure 87. Latin America Recombinant Therapeutic Protein Sales Market Share by Country in 2019
Figure 88. Latin America Recombinant Therapeutic Protein Revenue Market Share by Country in 2019
Figure 89. Mexico Recombinant Therapeutic Protein Sales Growth Rate (2015-2020) (K MT)
Figure 90. Mexico Recombinant Therapeutic Protein Revenue Growth Rate (2015-2020) (US$ Million)
Figure 91. Brazil Recombinant Therapeutic Protein Sales Growth Rate (2015-2020) (K MT)
Figure 92. Brazil Recombinant Therapeutic Protein Revenue Growth Rate (2015-2020) (US$ Million)
Figure 93. Argentina Recombinant Therapeutic Protein Sales

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Antioxidant Vitamins Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 100

The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......

Global Clavulanate Potassium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86

The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030. North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......

Global Amoxicillin Sodium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 84

The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030. North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......

Global Melatonin Supplements Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106

The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......

Global Sleeping Pills (Prescription Drugs) Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 93

The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......

Global Sleeping Pills Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94

The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......

Global Zinc Oral Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......

Global Zinc Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......

Global Anti-Infectives Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78

The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs